Home›Companies›Biotech & Pharma›Resolute Science

Resolute Science, Inc.

Develops cancer treatments for people with solid tumors.

Updated Nov 10, 2026·Latest SEC filing Apr 3, 2026·Suggest an edit

About Resolute Science

Resolute Science is a private company based in San Diego, California. It has reported $3,175,000 raised in two offerings on Form D since May 2024. Its chief executive is Andre Basbaum.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 3, 2025Feb 10, 2025amended Apr 3, 2026$2,925,000of $4.0M target25$117KDebt, Securities on exerciseRule 506(b)Form D/A ↗1 earlier filing
May 10, 2024May 16, 2024$250,000of $5.0M target1$250KSecurities on exerciseRule 506(b)Form D ↗
Total, two offerings$3,175,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Resolute Science's Form D filed Apr 3, 2026.

James Mackay
James Mackay
Independent Chairman
Also a director at Arthrosi Therapeutics.
Andre Basbaum
Andre Basbaum
President & CEO, director
Faith Barnett
Faith Barnett
Founder & CSO, director

Sources

  1. SECResolute Science, Inc. Form D, filed Feb 10, 2025
  2. SECResolute Science, Inc. filing history
  3. CompanyResolute Science privacy policy
  4. CompanyResolute Science team